Introduction
Numerous cellular abnormalities of heart muscle are associated with ventricular dysfunction and the clinical syndrome of heart failure. Many of these changes have been described in animal models of heart failure where there is considerable species and model variation' 112 '. The increasing use of cardiac transplantation has provided access to fresh myocardial tissue from severely failing human hearts and this has generated a large volume of experimental data.
A classification of the cellular abnormalities encountered in the failing human heart is provided in Table 1 . The relative contributions of each mechanism depend on the underlying aetiology of heart failure and different mechanisms may predominate at various times in the natural history of a particular disease.
Myocyte death
Heart failure in the setting of acute cardiogenic shock secondary to an extensive myocardial infarction is an example where a relatively well defined single mechanism is operative i.e. insufficient numbers of viable myocytes remain to sustain effective contraction' 31 . Under these conditions a fairly close relationship exists between myocyte loss and functional impairment' 4 '. Myocyte loss is also prominent in more chronic forms of heart failure secondary to both ischaemia' 51 and dilated cardiomyopathy* 61 , but here there is a weaker correlation between histological abnormalities and the severity of longstanding heart failure 
Disruption of the extracellular matrix
The role of the extracellular matrix in maintaining the physical structure of the heart and in the transmission of mechanical force to the circulation dictates that alterations in matrix composition have potentially important consequences for myocardial function (reviewed in' 8 '). There is an increase in the collagen content of failing myocardium' 5 ' 9 ', due to increases in types I and III collagen with a proportionately greater increase in type I' 9 '. Alterations in collagen architecture (but not increases in collagen volume) have been shown to correlate with abnormalities of passive relaxation in aortic valve disease ' l0 ', but in general attempts to correlate the degree of histological fibrosis with functional abnormalities in heart failure have yielded inconsistent results'"" 131 . There has been a considerable amount of animal research directed at identifying the mechanisms involved in coupling increased haemodynamic load to the production of myocyte hypertrophy. Interest has centred on changes in gene expression secondary to increases in cell loading and the actions of peptide growth factors (reviewed in' 22 * 231 ). However, there is a paucity of data from human studies on these mechanisms due to the nonavailability of appropriate human tissue. The elevated levels of myotrophin' 241 and endothelin' 251 detectable in human heart failure provide evidence of possible stimuli to the hypertrophic process in man.
Structural change in cardiac myocytes
In contrast to the certainty as to the occurrence of hypertrophy in heart failure, is the controversy surrounding whether there might be progression to hyperplasia and myocyte proliferation under certain conditions' 261 . Despite some evidence to the contrary 1271 , the established view has been that the adult cardiac myocyte is terminally differentiated and thus incapable of mitotic division' 28 ' 29 ' . This view has recently been challenged by careful morphometric studies demonstrating an increase in the number of myocytes in addition to the well recognised increases in myocyte size' 30 ' 31 '. This appears to occur not during the early phases of adaptation to increased load but in association with the latter stags of dilatation and myocardial failure. These findings await further confirmation, but they raise important questions about a potential role for hyperplasia in the transition from hypertrophy as a beneficial adaptation to the one that is a cause of mortality.
Ultrastructural change
The most prominent feature is one of loss of myofibrils 16 
Functional changes in ventricular myocytes
Although the structural changes outlined above are clearly important in the pathogenesis of chronic heart failure, there are additional functional changes that are present in myocytes which appear morphologically intact. There has been previous uncertainty as to whether impaired contractility could be demonstrated in isolated preparations, with some studies demonstrating a reduction in contractility in isometric myocardial preparations' 37 481 . This frequency-dependent impairment of function is consistent with clinical evidence demonstrating that a reduced cardiac output in heart failure is only apparent at higher heart rates'
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. With the demonstration of impaired myocardial function in heart failure at the level of individual myocytes the question arises as to which components in the excitation-contraction process are at fault.
Physiology of excitation-contraction coupling
The proposed mechanisms responsible for excitationcontraction (EC) coupling have been comprehensively reviewed' 50 '
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. The finding that depressed contractility in heart failure is dependent on stimulation rate has focused interest on those sub-cellular mechanisms thought to be responsible for frequency-dependent behaviour in the myocardium: the L-type Ca 2+ channel, the sarcoplasmic reticulum and the Na + -Ca 
Abnormalities of excitation-contraction coupling in heart failure
Before setting out the abnormalities associated with heart failure, it is important to bear in mind the limitations of some of the biochemical techniques involved. In particular the fact that changes in the concentration or activity of a particular substance must be interpreted with reference to a standard which is not itself subject to change in heart failure (typically per mg of total protein). Recent work by Bohm's group has challenged the tacit assumption that normalization per mg of total protein provides satisfactory standardization' 561 . Levels of the G protein G^ were found to be elevated by 139% in dilated cardiomyopathy and by 58% in ischaemic cardiomyopathy when referenced to total protein, but to be increased by 135% and 155% respectively when normalized to the sarcolemmal membrane marker of 3 H-ouabain binding sites (although this itself is not without its limitations -see below). The implication is that non-viable or non-myocyte tissue is diluting the sample in ischaemic but not dilated cardiomyopathy. Similar concerns have arisen concerning the use of /?-actin as a standard in studies examining changes in mRNA levels in heart failure. 2] . Nevertheless, the balance of functional evidence would seem to suggest that L-type channel conductance is not impaired in heart failure.
Sarcoplasmic reticulum Ca
2+ release channels This is an area of controversy with some groups reporting a reduction in the ryanodine sensitive release channel mRNA in ischaemic 173 ' but not dilated cardiomyopathy 173 -741 with others describing reductions in both ischaemic and dilated cardiomyopathy 1751 . It has been suggested that these reductions are associated with upregulation of the inositol 1,4,5,-triphosphate (ins(l,4,5)P 3 ) triggered Ca 2+ release channel'
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. However, the role played by the ins(l,4,5)P 3 channel in the physiology of human EC coupling is uncertain and the significance of this observation awaits confirmation. The sensitivity of mRNA techniques in general must be weighed against the fact that alterations in translation rates and protein turnover mean that changes in mRNA do not necessarily equate to changes in protein levels or to altered function. Single channel recordings have been unable to detect differences between ryanodine-sensitive release channel function in failing human heart compared with non-failing sheep hearts' 761 .
Ca 2+ transient
There is general agreement on the prolonged diastolic decay of the transient in heart failure ( Table 2 ) and this is in accord with the prolonged relaxation noted in isolated ventricular myocytes' 161 from failing hearts and [79] and Beukelmann et al. [64] . Some of these apparent discrepancies may relate to the use of right ventricular samples and the lower temperatures used by Gwathmey (Table 3) , the only exception being the study of Movsesian et al. [82] . . This appears to be functionally significant as inhibition of SERCA2a produces a greater prolongation of relaxation in myocytes from non-failing hearts than in those from patients with heart failure, implying that myocytes from failing hearts are better adapted to SR dysfunction'
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. Thus the weight of evidence, particularly from functional studies, would therefore seem to favour an abnormality of SR Ca 2+ uptake secondary to an abnormality of SERCA2a with uncertainty surrounding the function of phospholamban.
Myofilament abnormalities
Myofilament Ca 2+ sensitivity Studies have been performed on skinned fibre preparations in an attempt to assess the function of the myofilaments separately from the controlling influence of the Ca 2+ regulatory apparatus. The majority of these have failed to demonstrate an overall reduction in Ca 991 . The fact that no study has demonstrated reduced myofilament Ca 2+ sensitivity implies that this is not a mechanism for the impaired systolic function in the failing heart.
Alterations in myofilament composition
The total myosin content and myofibrillar Mg-ATPase are reduced in the failing heart' 102 ' 1031 and although this is in keeping with the histological descriptions of a reduced number of myofibrils' 47] , on the basis of myothermal measurements, have demonstrated no reduction in the efficiency of EC coupling to mechanical work, again supporting evidence in favour of an abnormality of Ca 2+ control over one of myofilament function.
Could myofilament abnormalities play a role in diastolic dysfunction? There is some evidence to support this from myothermal work demonstrating prolongation of the crossbridge force-time integral in myocardium from failing hearts' 1021 . Decreases in the atrial-like light chain 2 content of ventricular myocardium in dilated cardiomyopathy 11061 have been postulated to slow crossbridge dissociation' 1071 as might the modest increases of the TnT 2 isoform of troponin T that have been reported' 1081 . The interest generated by these findings must be tempered by the fact that similar abnormalities of the crossbridge force-time interval are also found in elderly non-failing hearts' 102 ' and thus the contribution of these abnormalities to diastolic dysfunctic uncertain.
Abnormalities of energy utilization
In a small series, Bashore et al. have described reduced ATP levels in endomyocardial biopsies from failing hearts and correlated these with the depression of ejection fraction' 121 , while Schultheiss et al. have demonstrated dysfunction of the mitochondrial ADP/ATP carrier in dilated but not ischaemic cardiomyopathy 11091 . In contrast, studies of ATP in heart failure using surgical biopsies (where the time between tissue harvest and freezing will have been shorter) have not demonstrated depression of ATP levels'" 01 . Some investigators have described a reduction in the ratio of phosphocreatine to ATP levels in dilated cardiomyopathy using 31 P MRI studies'" 11 but this finding has not been confirmed by others" 12 '. There are several reasons to doubt that a depressed level of ATP is a significant cause of contractile dysfunction in chronic heart failure. Firstly, there are technical difficulties in the measurement of ATP in endomyocardial biopsy specimens and measurement of total adenine nucleotides has failed to show reduced levels in heart failure 1 " 31 . Secondly, the Michaelis constants of both SERCA2a and myosin-ATPase are 1000 times less than cytosolic ATP levels' 114 ' 1151 suggesting that neither of these enzymes' activity is ATP-limited. Thirdly, intracellular addition of ATP does not reverse the abnormalities in the Ca 2+ transient seen in heart failure 1641 .
Abnormalities of the $-adrenoceptor signalling system
The well-recognized /?-adrenoceptor down-regulation '
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, increases in G, protein' 56 '" 61 and up regulation of /?-adrenoceptor kinase activity 1 " 71 in heart failure have been recently reviewed in detail' 1181 and will not be covered here. Although the importance of a depressed /?-adrenoceptor axis in the impaired response to exercise is clear, recent interest has centred on a potential role for yS-adrenoceptor desensitization in the pathogenesis of progressive heart failure. The SOLVD trial'" 9 ' demonstrated that elevation of catecholamine levels in patients with asymptomatic left ventricular dysfunction preceded the development of heart failure, whilst sequential measurements in patients with stable heart failure have revealed progressive increases in plasma noradrenaline' 120 '. Several studies have demonstrated that there is a reduction of both basal adenylate cyclase ac- 
Conclusions
Structural changes are clearly of fundamental importance in the pathogenesis of heart failure, both in terms of a reduction in the total number of myocytes and in a reduction in the myofibril content of those remaining. Changes in the extracellular matrix probably play an important role both in the process of remodelling and in determining passive diastolic function (although conclusive evidence for this in humans is still lacking). In addition to this there are important functional abnormalities of the remaining viable myocytes contributing to both systolic and diastolic dysfunction. The evidence favours disturbance of the Ca 2+ regulatory mechanisms over myofilament abnormalities as the predominant contributor to these functional disturbances. There remains uncertainty concerning the abnormalities of the various subcellular organelles involved in Ca 2+ homeostasis, but the evidence is most convincing for an abnormality of sarcoplasmic reticulum Ca 2+ uptake, possibly with partial compensation by upregulation of the Na + -Ca 2+ exchanger. Whether this abnormality could be reversed by pharmacological intervention is unknown, nor is it known whether these changes are beneficial by reducing cardiac contraction and delaying cell death or harmful by contributing to diminished function of the heart as a pump. Future therapies for heart failure will need to be directed towards avoiding cell necrosis, promoting and controlling cell growth and possibly regulating increases in myocardial cell numbers.
